Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rick Matos"'
Autor:
Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, Diana Fernandez, Divya Mirchandani, Nathen Bopp, Patricia V. Aguilar, Jun-Gyu Park, Paula Pino Tamayo, Jennifer Delgado, Vinay Shivanna, Jordi B. Torrelles, Luis Martinez-Sobrido, Rick Matos, Scott C. Weaver, K. Jagannadha Sastry, Robert A. Newman
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 138, Iss , Pp 111457- (2021)
With continued expansion of the coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome 2 (SARS-CoV-2), both antiviral drugs as well as effective vaccines are desperately needed to treat patients at high risk of life-thre
Externí odkaz:
https://doaj.org/article/dda910ba45da4435882993e51252c403
Autor:
Robert A. Newman, Rick Matos, Hongyi Cai, Robert Harrod, Ravit Arav-Boger, K. Jagannadha Sastry
Publikováno v:
Journal of Experimental Pharmacology. 12:503-515
Over the past 15 years, investigators have reported on the utility and safety of cardiac glycosides for numerous health benefits including those as treatments for malignant disease, stroke-mediated ischemic injury and certain neurodegenerative diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d96a5f8a007fbad6f25603c423cacb12
https://doi.org/10.2147/jep.s273120
https://doi.org/10.2147/jep.s273120
Autor:
Rick Matos, Divya Mirchandani, Scott C. Weaver, Diana Fernández, Jordi B. Torrelles, Varun Dwivedi, Jennifer Delgado, Nathen E. Bopp, Kenneth S. Plante, Vinay Shivanna, Patricia V. Aguilar, Jun Gyu Park, Luis Martinez-Sobrido, Jessica A. Plante, Paula Pino Tamayo, Robert A. Newman, K. Jagannadha Sastry
Publikováno v:
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy, Vol 138, Iss, Pp 111457-(2021)
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2021, 138, pp.111457. ⟨10.1016/j.biopha.2021.111457⟩
Biomedicine & Pharmacotherapy, Vol 138, Iss, Pp 111457-(2021)
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2021, 138, pp.111457. ⟨10.1016/j.biopha.2021.111457⟩
International audience; With continued expansion of the coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome 2 (SARS-CoV-2), both antiviral drugs as well as effective vaccines are desperately needed to treat patients a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d18452adb7c085e622caba7e86dbc6
http://europepmc.org/articles/PMC7927596
http://europepmc.org/articles/PMC7927596